Cargando…
Risk of retinal vein occlusion in colorectal cancer patients receiving anti-vascular endothelial growth factors – a population-based cohort study
BACKGROUND: Anti−vascular endothelial growth factors (VEGFs) treatment has been associated with an increased risk of thromboembolic events. Therefore, the use of anti−VEGFs for patients with colorectal cancers (CRC) has raised concerns about the potential risk of retinal vein occlusion (RVO), an ocu...
Autores principales: | Lee, Wan-Ju Annabelle, Chung, Wei-Pang, Shao, Shih-Chieh, Lai, Edward Chia-Cheng, Chen, Yi-Chen, Ho, Chung-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265868/ https://www.ncbi.nlm.nih.gov/pubmed/37316803 http://dx.doi.org/10.1186/s12885-023-11037-4 |
Ejemplares similares
-
Evaluation of Systemic Endothelial Dysfunction in Retinal Vein Occlusions
por: Bozkurt, Erdinc, et al.
Publicado: (2022) -
Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
por: Kim, Moosang
Publicado: (2016) -
Five-year outcomes of retinal vein occlusion treated with vascular endothelial growth factor inhibitors
por: Spooner, Kimberly, et al.
Publicado: (2019) -
Outcomes of Eyes Lost to Follow-Up in Patients with Central Retinal Vein Occlusion Who are Receiving Anti-Vascular Endothelial Growth Factor Treatment
por: Yang, Kai-Bo, et al.
Publicado: (2021) -
Branch Retinal Vein Occlusion followed by Central Retinal Vein Occlusion
por: Moradian, Siamak, et al.
Publicado: (2009)